* Avid Bioservices Inc CDMO.OQ reported quarterly adjusted
earnings of 2 cents per share for the quarter ended in July.
The mean expectation of four analysts for the quarter was
for earnings of 4 cents per share.
* Revenue rose 19.3% to $36.69 million from a year ago;
analysts
expected $33.44 million.
* Avid Bioservices Inc's reported EPS for the quarter was 2
cents.
* The mean earnings estimate of analysts had fallen by
about 8.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Avid Bioservices Inc shares had risen by 5.3% this
quarter and
lost 44.9% so far this year.
* The company reported quarterly net income of $1.56
million.
* Wall Street's median 12-month price target for Avid
Bioservices
Inc is $28.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data September
6 at 09:00 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jul. 31 2022 0.04 0.02 Missed
Apr. 30 2022 0.01 0.01 Met
Jan. 31 2022 0.04 0.04 Met
Oct. 31 2021 0.03 0.06 Beat